Global Nicotine Lozenges Market
Global Nicotine Lozenges Market

Nicotine Lozenges Comprehensive Study by Type (Gluten-Free, Latex-Free), Application (Male, Female), Distribution Channel (Retail Store, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Strength (2 mg, 4 mg, Others) Players and Region - Global Market Outlook to 2026

Nicotine Lozenges Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Apr 2021 Edition 232 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Nicotine Lozenges Market Scope?
Nicotine gum and lozenges are each popular and convenient forms of nicotine replacement medical care. These are smoking cessation products that facilitate smokers’ bit by bit overcome drug addiction. Nicotine is free by chewing the gum or lozenge and it's absorbed into the blood through the liner of the mouth, that bit by bit reduces smokers’ want for nicotine. Nicotine Lozenges are hard candy-like pill that contains a dose of nicotine polacrilex and dissolves slowly within the mouth to release the nicotine over the course of twenty to half-hour. It helps individuals in quitting the habit of smoking. to beat drug addiction these smoking stop products facilitate smokers. These products facilitate in relieving the symptoms that occur once a smoker tries to quit smoking. Nicotine Lozenges are absorbed through the liner of the mouth and enter into the blood vessels that are usually accessible over the counter usually found in two mg, four mg strengths, and alternative strengths are accessible. Nicotine lozenges are accessible in numerous flavors, brands and a number of other varieties and dosages are accessible according to nicotine dependence. It's prescribed and prompt by the doctors to not use over lozenges in 6 hours or twenty lozenges per day. It's counseled that nicotine lozenges are to be unbroken within the original container, at room temperature removed from excessive heat or wet.

The Nicotine Lozenges market study is being classified by Type (Gluten-Free and Latex-Free), by Application (Male and Female) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Vendors from United States will contribute to the maximum growth of Global Nicotine Lozenges market throughout the predicted period.

Cipla Ltd. (India), GlaxoSmithKline plc (United Kingdom), Johnson & Johnson (United States), Novartis International AG (Switzerland), Pfizer, Inc. (United States), Perrigo Company plc (Ireland), ITC Limited (India), Dr. Reddy's Laboratories (India) and Takeda Pharmaceutical Co., Ltd. (Japan) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Nicotine Lozenges market by Type, Application and Region.

On the basis of geography, the market of Nicotine Lozenges has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

On 14th July 2020, Dr.Reddy’s had launched over-the-counter Nicotine Polacriles Lozenges in the United States market. These lozenges will be used for the cessation of smoking. The launch is under the brand version of Nicorette Lozenges in the US market.


Influencing Market Trend
  • Rising Trend in The Increasing Awareness About the Ill Effects
  • Increase in School-Based Educational Campaigns

Market Drivers
  • Increase in The Cases of Lung Cancer
  • Increasing Smoking Cigarettes
  • Increasing Cases Regarding Cardiac Issues

Opportunities
  • Initiatives by Government to Impose High Tax on Public
  • Government to Ban Cigarette Products in Public Places

Restraints
  • Fluctuating Price of Raw Materials
  • High Cost of The Product

Challenges
  • Lack of Awareness of the Cessation Aid


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Nicotine Lozenges, Suppliers and Distributors of Nicotine Lozenges, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Gluten-Free
  • Latex-Free
By Application
  • Male
  • Female
By Distribution Channel
  • Retail Store
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Strength
  • 2 mg
  • 4 mg
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in The Cases of Lung Cancer
      • 3.2.2. Increasing Smoking Cigarettes
      • 3.2.3. Increasing Cases Regarding Cardiac Issues
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness of the Cessation Aid
    • 3.4. Market Trends
      • 3.4.1. Rising Trend in The Increasing Awareness About the Ill Effects
      • 3.4.2. Increase in School-Based Educational Campaigns
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nicotine Lozenges, by Type, Application, Distribution Channel, Strength and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Nicotine Lozenges (Value)
      • 5.2.1. Global Nicotine Lozenges by: Type (Value)
        • 5.2.1.1. Gluten-Free
        • 5.2.1.2. Latex-Free
      • 5.2.2. Global Nicotine Lozenges by: Application (Value)
        • 5.2.2.1. Male
        • 5.2.2.2. Female
      • 5.2.3. Global Nicotine Lozenges by: Distribution Channel (Value)
        • 5.2.3.1. Retail Store
        • 5.2.3.2. Hospital Pharmacies
        • 5.2.3.3. Retail Pharmacies
        • 5.2.3.4. Online Pharmacies
      • 5.2.4. Global Nicotine Lozenges by: Strength (Value)
        • 5.2.4.1. 2 mg
        • 5.2.4.2. 4 mg
        • 5.2.4.3. Others
      • 5.2.5. Global Nicotine Lozenges Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Nicotine Lozenges (Volume)
      • 5.3.1. Global Nicotine Lozenges by: Type (Volume)
        • 5.3.1.1. Gluten-Free
        • 5.3.1.2. Latex-Free
      • 5.3.2. Global Nicotine Lozenges by: Application (Volume)
        • 5.3.2.1. Male
        • 5.3.2.2. Female
      • 5.3.3. Global Nicotine Lozenges by: Distribution Channel (Volume)
        • 5.3.3.1. Retail Store
        • 5.3.3.2. Hospital Pharmacies
        • 5.3.3.3. Retail Pharmacies
        • 5.3.3.4. Online Pharmacies
      • 5.3.4. Global Nicotine Lozenges by: Strength (Volume)
        • 5.3.4.1. 2 mg
        • 5.3.4.2. 4 mg
        • 5.3.4.3. Others
      • 5.3.5. Global Nicotine Lozenges Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Nicotine Lozenges (Price)
      • 5.4.1. Global Nicotine Lozenges by: Type (Price)
  • 6. Nicotine Lozenges: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cipla Ltd. (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis International AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Perrigo Company plc (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ITC Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Dr. Reddy's Laboratories (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Takeda Pharmaceutical Co., Ltd. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Nicotine Lozenges Sale, by Type, Application, Distribution Channel, Strength and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Nicotine Lozenges (Value)
      • 7.2.1. Global Nicotine Lozenges by: Type (Value)
        • 7.2.1.1. Gluten-Free
        • 7.2.1.2. Latex-Free
      • 7.2.2. Global Nicotine Lozenges by: Application (Value)
        • 7.2.2.1. Male
        • 7.2.2.2. Female
      • 7.2.3. Global Nicotine Lozenges by: Distribution Channel (Value)
        • 7.2.3.1. Retail Store
        • 7.2.3.2. Hospital Pharmacies
        • 7.2.3.3. Retail Pharmacies
        • 7.2.3.4. Online Pharmacies
      • 7.2.4. Global Nicotine Lozenges by: Strength (Value)
        • 7.2.4.1. 2 mg
        • 7.2.4.2. 4 mg
        • 7.2.4.3. Others
      • 7.2.5. Global Nicotine Lozenges Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Nicotine Lozenges (Volume)
      • 7.3.1. Global Nicotine Lozenges by: Type (Volume)
        • 7.3.1.1. Gluten-Free
        • 7.3.1.2. Latex-Free
      • 7.3.2. Global Nicotine Lozenges by: Application (Volume)
        • 7.3.2.1. Male
        • 7.3.2.2. Female
      • 7.3.3. Global Nicotine Lozenges by: Distribution Channel (Volume)
        • 7.3.3.1. Retail Store
        • 7.3.3.2. Hospital Pharmacies
        • 7.3.3.3. Retail Pharmacies
        • 7.3.3.4. Online Pharmacies
      • 7.3.4. Global Nicotine Lozenges by: Strength (Volume)
        • 7.3.4.1. 2 mg
        • 7.3.4.2. 4 mg
        • 7.3.4.3. Others
      • 7.3.5. Global Nicotine Lozenges Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Nicotine Lozenges (Price)
      • 7.4.1. Global Nicotine Lozenges by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nicotine Lozenges: by Type(USD Million)
  • Table 2. Nicotine Lozenges Gluten-Free , by Region USD Million (2015-2020)
  • Table 3. Nicotine Lozenges Latex-Free , by Region USD Million (2015-2020)
  • Table 4. Nicotine Lozenges: by Application(USD Million)
  • Table 5. Nicotine Lozenges Male , by Region USD Million (2015-2020)
  • Table 6. Nicotine Lozenges Female , by Region USD Million (2015-2020)
  • Table 7. Nicotine Lozenges: by Distribution Channel(USD Million)
  • Table 8. Nicotine Lozenges Retail Store , by Region USD Million (2015-2020)
  • Table 9. Nicotine Lozenges Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 10. Nicotine Lozenges Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Nicotine Lozenges Online Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Nicotine Lozenges: by Strength(USD Million)
  • Table 13. Nicotine Lozenges 2 mg , by Region USD Million (2015-2020)
  • Table 14. Nicotine Lozenges 4 mg , by Region USD Million (2015-2020)
  • Table 15. Nicotine Lozenges Others , by Region USD Million (2015-2020)
  • Table 16. South America Nicotine Lozenges, by Country USD Million (2015-2020)
  • Table 17. South America Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 18. South America Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 19. South America Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 20. South America Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 21. Brazil Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 22. Brazil Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 23. Brazil Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 24. Brazil Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 25. Argentina Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 26. Argentina Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 27. Argentina Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 28. Argentina Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 29. Rest of South America Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 31. Rest of South America Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 32. Rest of South America Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 33. Asia Pacific Nicotine Lozenges, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 37. Asia Pacific Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 38. China Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 39. China Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 40. China Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 41. China Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 42. Japan Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 43. Japan Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 44. Japan Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 45. Japan Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 46. India Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 47. India Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 48. India Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 49. India Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 50. South Korea Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 51. South Korea Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 52. South Korea Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 53. South Korea Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 54. Taiwan Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 55. Taiwan Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 56. Taiwan Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 57. Taiwan Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 58. Australia Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 59. Australia Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 60. Australia Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 61. Australia Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 66. Europe Nicotine Lozenges, by Country USD Million (2015-2020)
  • Table 67. Europe Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 68. Europe Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 69. Europe Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 70. Europe Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 71. Germany Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 72. Germany Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 73. Germany Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 74. Germany Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 75. France Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 76. France Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 77. France Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 78. France Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 79. Italy Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 80. Italy Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 81. Italy Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 82. Italy Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 83. United Kingdom Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 85. United Kingdom Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 86. United Kingdom Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 87. Netherlands Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 88. Netherlands Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 89. Netherlands Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 90. Netherlands Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 91. Rest of Europe Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 93. Rest of Europe Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 94. Rest of Europe Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 95. MEA Nicotine Lozenges, by Country USD Million (2015-2020)
  • Table 96. MEA Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 97. MEA Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 98. MEA Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 99. MEA Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 100. Middle East Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 101. Middle East Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 102. Middle East Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 103. Middle East Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 104. Africa Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 105. Africa Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 106. Africa Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 107. Africa Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 108. North America Nicotine Lozenges, by Country USD Million (2015-2020)
  • Table 109. North America Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 110. North America Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 111. North America Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 112. North America Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 113. United States Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 114. United States Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 115. United States Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 116. United States Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 117. Canada Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 118. Canada Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 119. Canada Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 120. Canada Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 121. Mexico Nicotine Lozenges, by Type USD Million (2015-2020)
  • Table 122. Mexico Nicotine Lozenges, by Application USD Million (2015-2020)
  • Table 123. Mexico Nicotine Lozenges, by Distribution Channel USD Million (2015-2020)
  • Table 124. Mexico Nicotine Lozenges, by Strength USD Million (2015-2020)
  • Table 125. Nicotine Lozenges Sales: by Type(K Units)
  • Table 126. Nicotine Lozenges Sales Gluten-Free , by Region K Units (2015-2020)
  • Table 127. Nicotine Lozenges Sales Latex-Free , by Region K Units (2015-2020)
  • Table 128. Nicotine Lozenges Sales: by Application(K Units)
  • Table 129. Nicotine Lozenges Sales Male , by Region K Units (2015-2020)
  • Table 130. Nicotine Lozenges Sales Female , by Region K Units (2015-2020)
  • Table 131. Nicotine Lozenges Sales: by Distribution Channel(K Units)
  • Table 132. Nicotine Lozenges Sales Retail Store , by Region K Units (2015-2020)
  • Table 133. Nicotine Lozenges Sales Hospital Pharmacies , by Region K Units (2015-2020)
  • Table 134. Nicotine Lozenges Sales Retail Pharmacies , by Region K Units (2015-2020)
  • Table 135. Nicotine Lozenges Sales Online Pharmacies , by Region K Units (2015-2020)
  • Table 136. Nicotine Lozenges Sales: by Strength(K Units)
  • Table 137. Nicotine Lozenges Sales 2 mg , by Region K Units (2015-2020)
  • Table 138. Nicotine Lozenges Sales 4 mg , by Region K Units (2015-2020)
  • Table 139. Nicotine Lozenges Sales Others , by Region K Units (2015-2020)
  • Table 140. South America Nicotine Lozenges Sales, by Country K Units (2015-2020)
  • Table 141. South America Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 142. South America Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 143. South America Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 144. South America Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 145. Brazil Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 146. Brazil Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 147. Brazil Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 148. Brazil Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 149. Argentina Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 150. Argentina Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 151. Argentina Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 152. Argentina Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 153. Rest of South America Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 154. Rest of South America Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 155. Rest of South America Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 156. Rest of South America Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 157. Asia Pacific Nicotine Lozenges Sales, by Country K Units (2015-2020)
  • Table 158. Asia Pacific Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 159. Asia Pacific Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 160. Asia Pacific Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 161. Asia Pacific Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 162. China Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 163. China Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 164. China Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 165. China Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 166. Japan Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 167. Japan Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 168. Japan Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 169. Japan Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 170. India Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 171. India Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 172. India Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 173. India Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 174. South Korea Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 175. South Korea Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 176. South Korea Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 177. South Korea Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 178. Taiwan Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 179. Taiwan Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 180. Taiwan Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 181. Taiwan Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 182. Australia Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 183. Australia Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 184. Australia Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. Australia Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 186. Rest of Asia-Pacific Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 187. Rest of Asia-Pacific Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 188. Rest of Asia-Pacific Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 189. Rest of Asia-Pacific Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 190. Europe Nicotine Lozenges Sales, by Country K Units (2015-2020)
  • Table 191. Europe Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 192. Europe Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 193. Europe Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 194. Europe Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 195. Germany Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 196. Germany Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 197. Germany Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 198. Germany Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 199. France Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 200. France Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 201. France Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 202. France Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 203. Italy Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 204. Italy Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 205. Italy Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 206. Italy Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 207. United Kingdom Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 208. United Kingdom Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 209. United Kingdom Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 210. United Kingdom Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 211. Netherlands Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 212. Netherlands Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 213. Netherlands Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 214. Netherlands Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 215. Rest of Europe Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 216. Rest of Europe Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 217. Rest of Europe Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 218. Rest of Europe Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 219. MEA Nicotine Lozenges Sales, by Country K Units (2015-2020)
  • Table 220. MEA Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 221. MEA Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 222. MEA Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 223. MEA Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 224. Middle East Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 225. Middle East Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 226. Middle East Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 227. Middle East Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 228. Africa Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 229. Africa Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 230. Africa Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 231. Africa Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 232. North America Nicotine Lozenges Sales, by Country K Units (2015-2020)
  • Table 233. North America Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 234. North America Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 235. North America Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 236. North America Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 237. United States Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 238. United States Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 239. United States Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 240. United States Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 241. Canada Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 242. Canada Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 243. Canada Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 244. Canada Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 245. Mexico Nicotine Lozenges Sales, by Type K Units (2015-2020)
  • Table 246. Mexico Nicotine Lozenges Sales, by Application K Units (2015-2020)
  • Table 247. Mexico Nicotine Lozenges Sales, by Distribution Channel K Units (2015-2020)
  • Table 248. Mexico Nicotine Lozenges Sales, by Strength K Units (2015-2020)
  • Table 249. Nicotine Lozenges: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Nicotine Lozenges: by Type(USD Million)
  • Table 260. Nicotine Lozenges Gluten-Free , by Region USD Million (2021-2026)
  • Table 261. Nicotine Lozenges Latex-Free , by Region USD Million (2021-2026)
  • Table 262. Nicotine Lozenges: by Application(USD Million)
  • Table 263. Nicotine Lozenges Male , by Region USD Million (2021-2026)
  • Table 264. Nicotine Lozenges Female , by Region USD Million (2021-2026)
  • Table 265. Nicotine Lozenges: by Distribution Channel(USD Million)
  • Table 266. Nicotine Lozenges Retail Store , by Region USD Million (2021-2026)
  • Table 267. Nicotine Lozenges Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 268. Nicotine Lozenges Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 269. Nicotine Lozenges Online Pharmacies , by Region USD Million (2021-2026)
  • Table 270. Nicotine Lozenges: by Strength(USD Million)
  • Table 271. Nicotine Lozenges 2 mg , by Region USD Million (2021-2026)
  • Table 272. Nicotine Lozenges 4 mg , by Region USD Million (2021-2026)
  • Table 273. Nicotine Lozenges Others , by Region USD Million (2021-2026)
  • Table 274. South America Nicotine Lozenges, by Country USD Million (2021-2026)
  • Table 275. South America Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 276. South America Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 277. South America Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 278. South America Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 279. Brazil Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 280. Brazil Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 281. Brazil Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 282. Brazil Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 283. Argentina Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 284. Argentina Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 285. Argentina Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 286. Argentina Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 287. Rest of South America Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 288. Rest of South America Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 289. Rest of South America Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 290. Rest of South America Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 291. Asia Pacific Nicotine Lozenges, by Country USD Million (2021-2026)
  • Table 292. Asia Pacific Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 293. Asia Pacific Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 294. Asia Pacific Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 295. Asia Pacific Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 296. China Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 297. China Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 298. China Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 299. China Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 300. Japan Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 301. Japan Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 302. Japan Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 303. Japan Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 304. India Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 305. India Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 306. India Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 307. India Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 308. South Korea Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 309. South Korea Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 310. South Korea Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 311. South Korea Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 312. Taiwan Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 313. Taiwan Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 314. Taiwan Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 315. Taiwan Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 316. Australia Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 317. Australia Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 318. Australia Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 319. Australia Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 320. Rest of Asia-Pacific Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 321. Rest of Asia-Pacific Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 322. Rest of Asia-Pacific Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 323. Rest of Asia-Pacific Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 324. Europe Nicotine Lozenges, by Country USD Million (2021-2026)
  • Table 325. Europe Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 326. Europe Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 327. Europe Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 328. Europe Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 329. Germany Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 330. Germany Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 331. Germany Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 332. Germany Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 333. France Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 334. France Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 335. France Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 336. France Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 337. Italy Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 338. Italy Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 339. Italy Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 340. Italy Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 341. United Kingdom Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 342. United Kingdom Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 343. United Kingdom Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 344. United Kingdom Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 345. Netherlands Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 346. Netherlands Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 347. Netherlands Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 348. Netherlands Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 349. Rest of Europe Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 350. Rest of Europe Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 351. Rest of Europe Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 352. Rest of Europe Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 353. MEA Nicotine Lozenges, by Country USD Million (2021-2026)
  • Table 354. MEA Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 355. MEA Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 356. MEA Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 357. MEA Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 358. Middle East Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 359. Middle East Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 360. Middle East Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 361. Middle East Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 362. Africa Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 363. Africa Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 364. Africa Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 365. Africa Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 366. North America Nicotine Lozenges, by Country USD Million (2021-2026)
  • Table 367. North America Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 368. North America Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 369. North America Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 370. North America Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 371. United States Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 372. United States Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 373. United States Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 374. United States Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 375. Canada Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 376. Canada Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 377. Canada Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 378. Canada Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 379. Mexico Nicotine Lozenges, by Type USD Million (2021-2026)
  • Table 380. Mexico Nicotine Lozenges, by Application USD Million (2021-2026)
  • Table 381. Mexico Nicotine Lozenges, by Distribution Channel USD Million (2021-2026)
  • Table 382. Mexico Nicotine Lozenges, by Strength USD Million (2021-2026)
  • Table 383. Nicotine Lozenges Sales: by Type(K Units)
  • Table 384. Nicotine Lozenges Sales Gluten-Free , by Region K Units (2021-2026)
  • Table 385. Nicotine Lozenges Sales Latex-Free , by Region K Units (2021-2026)
  • Table 386. Nicotine Lozenges Sales: by Application(K Units)
  • Table 387. Nicotine Lozenges Sales Male , by Region K Units (2021-2026)
  • Table 388. Nicotine Lozenges Sales Female , by Region K Units (2021-2026)
  • Table 389. Nicotine Lozenges Sales: by Distribution Channel(K Units)
  • Table 390. Nicotine Lozenges Sales Retail Store , by Region K Units (2021-2026)
  • Table 391. Nicotine Lozenges Sales Hospital Pharmacies , by Region K Units (2021-2026)
  • Table 392. Nicotine Lozenges Sales Retail Pharmacies , by Region K Units (2021-2026)
  • Table 393. Nicotine Lozenges Sales Online Pharmacies , by Region K Units (2021-2026)
  • Table 394. Nicotine Lozenges Sales: by Strength(K Units)
  • Table 395. Nicotine Lozenges Sales 2 mg , by Region K Units (2021-2026)
  • Table 396. Nicotine Lozenges Sales 4 mg , by Region K Units (2021-2026)
  • Table 397. Nicotine Lozenges Sales Others , by Region K Units (2021-2026)
  • Table 398. South America Nicotine Lozenges Sales, by Country K Units (2021-2026)
  • Table 399. South America Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 400. South America Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 401. South America Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 402. South America Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 403. Brazil Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 404. Brazil Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 405. Brazil Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 406. Brazil Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 407. Argentina Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 408. Argentina Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 409. Argentina Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 410. Argentina Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 411. Rest of South America Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 412. Rest of South America Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 413. Rest of South America Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 414. Rest of South America Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 415. Asia Pacific Nicotine Lozenges Sales, by Country K Units (2021-2026)
  • Table 416. Asia Pacific Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 417. Asia Pacific Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 418. Asia Pacific Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 419. Asia Pacific Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 420. China Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 421. China Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 422. China Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 423. China Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 424. Japan Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 425. Japan Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 426. Japan Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 427. Japan Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 428. India Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 429. India Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 430. India Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 431. India Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 432. South Korea Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 433. South Korea Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 434. South Korea Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 435. South Korea Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 436. Taiwan Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 437. Taiwan Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 438. Taiwan Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 439. Taiwan Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 440. Australia Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 441. Australia Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 442. Australia Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 443. Australia Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 444. Rest of Asia-Pacific Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 445. Rest of Asia-Pacific Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 446. Rest of Asia-Pacific Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 447. Rest of Asia-Pacific Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 448. Europe Nicotine Lozenges Sales, by Country K Units (2021-2026)
  • Table 449. Europe Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 450. Europe Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 451. Europe Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 452. Europe Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 453. Germany Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 454. Germany Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 455. Germany Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 456. Germany Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 457. France Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 458. France Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 459. France Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 460. France Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 461. Italy Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 462. Italy Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 463. Italy Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 464. Italy Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 465. United Kingdom Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 466. United Kingdom Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 467. United Kingdom Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 468. United Kingdom Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 469. Netherlands Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 470. Netherlands Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 471. Netherlands Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 472. Netherlands Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 473. Rest of Europe Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 474. Rest of Europe Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 475. Rest of Europe Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 476. Rest of Europe Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 477. MEA Nicotine Lozenges Sales, by Country K Units (2021-2026)
  • Table 478. MEA Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 479. MEA Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 480. MEA Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 481. MEA Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 482. Middle East Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 483. Middle East Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 484. Middle East Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 485. Middle East Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 486. Africa Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 487. Africa Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 488. Africa Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 489. Africa Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 490. North America Nicotine Lozenges Sales, by Country K Units (2021-2026)
  • Table 491. North America Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 492. North America Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 493. North America Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 494. North America Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 495. United States Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 496. United States Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 497. United States Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 498. United States Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 499. Canada Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 500. Canada Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 501. Canada Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 502. Canada Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 503. Mexico Nicotine Lozenges Sales, by Type K Units (2021-2026)
  • Table 504. Mexico Nicotine Lozenges Sales, by Application K Units (2021-2026)
  • Table 505. Mexico Nicotine Lozenges Sales, by Distribution Channel K Units (2021-2026)
  • Table 506. Mexico Nicotine Lozenges Sales, by Strength K Units (2021-2026)
  • Table 507. Nicotine Lozenges: by Type(USD/Units)
  • Table 508. Research Programs/Design for This Report
  • Table 509. Key Data Information from Secondary Sources
  • Table 510. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nicotine Lozenges: by Type USD Million (2015-2020)
  • Figure 5. Global Nicotine Lozenges: by Application USD Million (2015-2020)
  • Figure 6. Global Nicotine Lozenges: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Nicotine Lozenges: by Strength USD Million (2015-2020)
  • Figure 8. South America Nicotine Lozenges Share (%), by Country
  • Figure 9. Asia Pacific Nicotine Lozenges Share (%), by Country
  • Figure 10. Europe Nicotine Lozenges Share (%), by Country
  • Figure 11. MEA Nicotine Lozenges Share (%), by Country
  • Figure 12. North America Nicotine Lozenges Share (%), by Country
  • Figure 13. Global Nicotine Lozenges: by Type K Units (2015-2020)
  • Figure 14. Global Nicotine Lozenges: by Application K Units (2015-2020)
  • Figure 15. Global Nicotine Lozenges: by Distribution Channel K Units (2015-2020)
  • Figure 16. Global Nicotine Lozenges: by Strength K Units (2015-2020)
  • Figure 17. South America Nicotine Lozenges Share (%), by Country
  • Figure 18. Asia Pacific Nicotine Lozenges Share (%), by Country
  • Figure 19. Europe Nicotine Lozenges Share (%), by Country
  • Figure 20. MEA Nicotine Lozenges Share (%), by Country
  • Figure 21. North America Nicotine Lozenges Share (%), by Country
  • Figure 22. Global Nicotine Lozenges: by Type USD/Units (2015-2020)
  • Figure 23. Global Nicotine Lozenges share by Players 2020 (%)
  • Figure 24. Global Nicotine Lozenges share by Players (Top 3) 2020(%)
  • Figure 25. Global Nicotine Lozenges share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Cipla Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 28. Cipla Ltd. (India) Revenue: by Geography 2020
  • Figure 29. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 32. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 33. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Novartis International AG (Switzerland) Revenue: by Geography 2020
  • Figure 35. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Perrigo Company plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 38. Perrigo Company plc (Ireland) Revenue: by Geography 2020
  • Figure 39. ITC Limited (India) Revenue, Net Income and Gross profit
  • Figure 40. ITC Limited (India) Revenue: by Geography 2020
  • Figure 41. Dr. Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 42. Dr. Reddy's Laboratories (India) Revenue: by Geography 2020
  • Figure 43. Takeda Pharmaceutical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 44. Takeda Pharmaceutical Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 45. Global Nicotine Lozenges: by Type USD Million (2021-2026)
  • Figure 46. Global Nicotine Lozenges: by Application USD Million (2021-2026)
  • Figure 47. Global Nicotine Lozenges: by Distribution Channel USD Million (2021-2026)
  • Figure 48. Global Nicotine Lozenges: by Strength USD Million (2021-2026)
  • Figure 49. South America Nicotine Lozenges Share (%), by Country
  • Figure 50. Asia Pacific Nicotine Lozenges Share (%), by Country
  • Figure 51. Europe Nicotine Lozenges Share (%), by Country
  • Figure 52. MEA Nicotine Lozenges Share (%), by Country
  • Figure 53. North America Nicotine Lozenges Share (%), by Country
  • Figure 54. Global Nicotine Lozenges: by Type K Units (2021-2026)
  • Figure 55. Global Nicotine Lozenges: by Application K Units (2021-2026)
  • Figure 56. Global Nicotine Lozenges: by Distribution Channel K Units (2021-2026)
  • Figure 57. Global Nicotine Lozenges: by Strength K Units (2021-2026)
  • Figure 58. South America Nicotine Lozenges Share (%), by Country
  • Figure 59. Asia Pacific Nicotine Lozenges Share (%), by Country
  • Figure 60. Europe Nicotine Lozenges Share (%), by Country
  • Figure 61. MEA Nicotine Lozenges Share (%), by Country
  • Figure 62. North America Nicotine Lozenges Share (%), by Country
  • Figure 63. Global Nicotine Lozenges: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Cipla Ltd. (India)
  • GlaxoSmithKline plc (United Kingdom)
  • Johnson & Johnson (United States)
  • Novartis International AG (Switzerland)
  • Pfizer, Inc. (United States)
  • Perrigo Company plc (Ireland)
  • ITC Limited (India)
  • Dr. Reddy's Laboratories (India)
  • Takeda Pharmaceutical Co., Ltd. (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation